# Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

> **NCT05705024** · PHASE2 · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 38 (estimated)

## Conditions studied

- Corneal Ulcer

## Interventions

- **BIOLOGICAL:** Mesenchymal Stromal Cells
- **OTHER:** Control Solution

## Key facts

- **NCT ID:** NCT05705024
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-29
- **Primary completion:** 2026-09-28
- **Final completion:** 2026-09-28
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05705024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05705024, "Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05705024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
